Finally, we used a mouse laser-CNV model of AMD to demonstrate that CNV sizes were enhanced by HTRA1 and/or oxLDL following laser photo-coagulation and that such enhancement can be neutralized with antibody to HTRA1, indicating the therapeutic potential of anti-HTRA1 in treating patients with wet AMD. This evidence concerns the gene HTRA1 and wet macular degeneration.